MigakiEAMelhartBJDewarCJHustonRK. Calcium chloride and sodium phosphate in neonatal parenteral nutrition containing TrophAmine: precipitation studies and aluminum content. JPEN J Parenter Enteral Nutr. 2012;36:470-475.
2.
DriscollDFNewtonDWBistrianBR. Calcium phosphate precipitation from parenteral nutrition. Am J Hosp Pharm. 1994:51:2834-2836.
3.
LumpkinMMBurlingtonDB. FDA Safety Alert: Hazards of Precipitation Associated with Parenteral Nutrition. Rockville, MD: Food and Drug Administration; April18, 1994.
4.
Food and Drug Administration. FDA safety alert: hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm. 1994;51:1427-1428.
5.
MadsenRECherrisRTShabushnigJG. Particulates in injections: a history and proposal to revise USP General Chapter Injection <1>. Pharm Forum. 2009;35:1383-1387.
6.
HillSEHeldmanLSGooEDHWhippoPEPerkinsonJC. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture. JPEN J Parenter Enteral Nutr. 1996;20:81-87.
7.
United States Pharmacopeial Convention, Inc. Particulate matter in injections. In: United States Pharmacopeia 34, National Formulary 29. Rockville, MD: United States Pharmacopeial Convention, Inc; 2011:326-328.
8.
DriscollDF. Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards. Curr Opin Clin Nutr Metab Care. 2005;8:297-303.
9.
ParikhMDumasGSilvetsriAP. Physical compatibility of neonatal TPN admixtures containing organic calcium and inorganic phosphate salts. Am J Health-Syst Pharm. 2005;62:1177-1183.
10.
SinghHDumasGJSilvestriAPBistrianBRDriscollDF. Physical compatibility of neonatal TPN admixtures containing organic calcium and inorganic phosphate salts in simulated infusion at 37°C. Ped Crit Care Med. 2009;10:213-216.
11.
JoyJSilvestriAPFrankeR. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. JPEN J Parenter Enteral Nutr. 2010;34:46-54.
12.
NewtonDWDriscollDF. Calcium and phosphate compatibility: revisited again. Am J Health-Syst Pharm. 2008;65:73-80.
13.
NewtonDWDriscollDF. Phosphates injections: chemistry and safety. Am J Health-Syst Pharm. 2008;65:1761-1766.
14.
A.S.P.E.N. Task Force. Special report: safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:S39-S70.
15.
DriscollDF. Compounding TPN admixtures: then and now. JPEN J Parenter Enteral Nutr. 2003;27:433-438.
16.
HenryRSJurgensRWSturgeonRAthanikarNWelcoAVan LeuvenM. Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution. Am J Hosp Pharm. 1980;37:673-674.
17.
YoungD. FDA aluminum rule poses challenges for industry, pharmacists. Am J Health-Syst Pharm. 2004;61:742, 744.
18.
DriscollMBDriscollDF. Calculating aluminum content in total parenteral nutrition admixtures. Am J Health-Syst Pharm. 2005;62:312-315.
19.
FauselCANewtonDWDriscollDF. Effect of fat emulsion and supersaturation on calcium phosphate solubility in parenteral nutrient admixtures. Int J Pharm Comp. 1997;1:54-59.
20.
BowmanBJOfnerCMIIISchottH. Colloidal dispersions. In: TroyDB, ed. Remington: The Science and Practice of Pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:308.
21.
RobinsonLAWrightBT. Central venous catheter occlusion caused by body-heat-mediated calcium phosphate precipitation. Am J Hosp Pharm. 1982;39:120-121.
22.
Korth-BradleyJMLudwigSCallaghanC. Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections. Am J Health-Syst Pharm. 1995;52:2340.